Warning: The NCBI web site requires JavaScript to function. more...
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A.
Arthritis Res Ther. 2009;11(3):R79. Epub 2009 May 28.
Related citations
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL, Graham KL, Lee LY, Balboni I, Hertzog PJ, Utz PJ.
Arthritis Res Ther. 2009;11(4):R112. Epub 2009 Jul 22.
Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
Lenert PS.
Arthritis Res Ther. 2006;8(1):203. Epub 2006 Jan 10. Review.
Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
Layer T, Steele A, Goeken JA, Fleenor S, Lenert P.
Clin Exp Immunol. 2011 Mar;163(3):392-403. doi: 10.1111/j.1365-2249.2010.04307.x. Epub 2011 Jan 14.
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, Marshak-Rothstein A.
J Exp Med. 2005 Nov 7;202(9):1171-7. Epub 2005 Oct 31.
Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R, Roberts TL, Stacey KJ, Lenert P.
Eur J Immunol. 2006 Jul;36(7):1951-62.
Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
FASEB J. 2004 Mar;18(3):534-6. Epub 2004 Jan 20.
Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, Akira S, Gotoh Y, Kiyono H, Miyake K.
Int Immunol. 2008 Jul;20(7):881-91. Epub 2008 May 19.
Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
Brummel R, Lenert P.
J Immunol. 2005 Feb 15;174(4):2429-34.
B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J, Mamula MJ.
Int Immunol. 2002 Aug;14(8):963-71.
B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
Beaudette-Zlatanova BC, Ling T, Shlomchik MJ, Marshak-Rothstein A, Rifkin IR.
J Immunol. 2006 Jul 1;177(1):45-52.
The central and multiple roles of B cells in lupus pathogenesis.
Chan OT, Madaio MP, Shlomchik MJ.
Immunol Rev. 1999 Jun;169:107-21. Review.
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.
Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, Garlanda C, Mantovani A, Anders HJ.
J Exp Med. 2008 Aug 4;205(8):1879-88. Epub 2008 Jul 21. Erratum in: J Exp Med. 2008 Sep 1;205(9):2179.
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.
Lenert P, Brummel R, Field EH, Ashman RF.
J Clin Immunol. 2005 Jan;25(1):29-40.
Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
Pawar RD, Patole PS, Ellwart A, Lech M, Segerer S, Schlondorff D, Anders HJ.
J Am Soc Nephrol. 2006 Dec;17(12):3365-73. Epub 2006 Nov 2.
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ.
Immunity. 2008 Aug 15;29(2):249-60.
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ.
Immunity. 2006 Sep;25(3):417-28.
B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA, Layer T, Fleenor S, Laccheo M, Lenert P.
Lupus. 2010 Oct;19(11):1290-301. Epub 2010 Jul 6.
Toll-like receptor-dependent immune complex activation of B cells and dendritic cells.
Uccellini MB, Avalos AM, Marshak-Rothstein A, Viglianti GA.
Methods Mol Biol. 2009;517:363-80.
Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
Fujii T, Okada M, Craft J.
Cell Immunol. 2002 May-Jun;217(1-2):23-35.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on